Globe Life price target lowered to $139 from $140 at Wells Fargo

Wells Fargo lowered the firm’s price target on Globe Life (GL) to $139 from $140 and keeps an Overweight rating on the shares. The firm notes the company brought down its full year margin guide for Health, but increased its margin guide for Life. Management sounded positive on the ability to reprice its med supp block and said it would see how the next quarters go in terms of seeking rate increase.